- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Poltreg SA (PTGP)
Track today's live Poltreg (PTGP) share price, performance and key data on this page with our current Warsaw:PTGP stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Poltreg share price on the Warsaw exchange. Use the dropdown to switch exchange for the PTGP share price, head to our technical summary section, which provides analysis on Poltreg share price buy/sell indicators using real-time data (or discuss the Poltreg (PTGP) stock price today with other investors in the Poltreg WA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current WA:PTGP share price (ISIN: PLPLTRG00038) to enhance your trading decisions with our free investment tools and resources.
What Is the Poltreg SA Share Price Today?
The Poltreg share price today is 24.00.
What Is the Stock Symbol for Poltreg SA
The stock symbol (or 'ticker') for Poltreg SA is "PTGP."
What Stock Exchange Does Poltreg SA Trade On?
Poltreg SA is listed and trades on the Warsaw stock exchange.
Is Poltreg SA a Good Stock to Buy?
Determining whether Poltreg (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current WA:PTGP share price (ISIN: PLPLTRG00038) to enhance your trading decisions with our free investment tools and resources.
What Is the Poltreg SA Share Price Today?
The Poltreg share price today is 24.00.
What Is the Stock Symbol for Poltreg SA
The stock symbol (or 'ticker') for Poltreg SA is "PTGP."
What Stock Exchange Does Poltreg SA Trade On?
Poltreg SA is listed and trades on the Warsaw stock exchange.
Is Poltreg SA a Good Stock to Buy?
Determining whether Poltreg (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Warsaw
Currency in PLN
24.00
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.00
24.00
52 wk Range
16.00
33.70
PTGP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.0024.00
52 wk Range
16.0033.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PTGP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
20/05/2026
EPS / Forecast
-1.45 / --
Revenue / Forecast
-- / --
Compare PTGP to Peers and Sector
Metrics to compare | PTGP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPTGPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.2x | −2.9x | −0.3x | |
PEG Ratio | 0.16 | 0.06 | 0.00 | |
Price/Book | 3.9x | 2.8x | 2.6x | |
Price / LTM Sales | - | 4.4x | 3.0x | |
Upside (Analyst Target) | 186.4% | 40.8% | 56.6% | |
Fair Value Upside | Unlock | 6.8% | 10.2% | Unlock |
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases in Poland. Its product pipeline includes PTG-OO7 + Rituximab which is in phase II clinical trial to treat presymptomatic T1D; MOG CAR-Treg which is in phase I clinical trial for the treatment of multiple sclerosis, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis; Multi-Edit/Allo MOG CAR-Treg which is in preclinical trial to treat multiple sclerosis, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis; and Antigen-specific T-regulatory cell (Tregs) which is in preclinical trial to treat T1D. The company also develops CD6/CTLA4 CAR-Treg which is in phase I clinical trial to treat stage 3 T1D; CD6/CTLA4 CAR-Treg which is in preclinical trial for the treatment of vitiligo, atopic derm, psoriasis, and alopecia areata; CD6/CTLA4 CAR-Treg which is in preclinical trial to treat multiple sclerosis, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis; and PTG-OO7 + Rituximab which is in preclinical trial to treat presympt T1D. In addition, it is developing cell therapies involve the use of human cells to regenerate a patient’s damaged tissues or organs. The company was founded in 2015 and is headquartered in Gdansk, Poland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Poltreg (Warsaw: PTGP) Share Price Today?
The Poltreg stock price today is 24.00 PLN.
What Stock Exchange Does Poltreg (PTGP) Trade On?
Poltreg is listed and trades on the Warsaw Stock Exchange.
What Is the Ticker (Stock Symbol) for Poltreg?
The stock symbol (also called a 'ticker') for Poltreg is "PTGP."
What Is the Current Poltreg Market Capitalisation?
As of today, Poltreg (Warsaw: PTGP) market cap is 141.99M PLN.
What Is Poltreg's (PTGP) Earnings Per Share (TTM)?
The Poltreg EPS is currently -5.86 (Trailing Twelve Months).
When Is the Next Poltreg Earnings Date?
Poltreg's next earnings report will be released on 10/09/2026.
Is PTGP a Buy or Sell From a Technical Analyst Perspective?
Based on today's Poltreg moving averages and other technical indicators, the daily buy/sell signal for PTGP stock is Strong Buy.
How Many Times Has Poltreg Stock Split?
Poltreg has split 0 times. (See the PTGP stock split history page for full effective split date and price information.)
How Many Employees Does Poltreg Have?
Poltreg has 37 employees, based on their latest Companies House report.
What is the current trading status of Poltreg (Warsaw: PTGP)?
As of 31/07/2026, Poltreg (PTGP) is trading at a share price of 24.00 PLN, with a previous close of 24.00 PLN. The stock has fluctuated within a day range of 23.00 PLN to 24.00 PLN, while its 52-week range spans from 16.00 PLN to 33.70 PLN.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.